Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. (PBAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PBAX · as of Jun 9, 2026
Key Statistics
Explore Phoenix Biotech Acquisition Corp. Data
pbax stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
pbax competitorsPBAX
ASCA
AVHI
BSGA
CNTM
GDNRStock Performance
Full HistoryAbout Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition,…
what is phoenix biotech acquisition corp. · pbax stock overview · phoenix biotech acquisition corp. company profile · who is phoenix biotech acquisition corp. ceo · pbax NASDAQ · phoenix biotech acquisition corp. headquarters · phoenix biotech acquisition corp. business segments
About Stock Overview & Key Data
Phoenix Biotech Acquisition Corp. (PBAX) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Nov 30, 2021. As of the latest trading session, PBAX stock price is $5.85, with a market capitalization of $36.5M. The stock has returned -45.22% over the past 12 months and -46.82% year-to-date.
In fiscal year 2025, Phoenix Biotech Acquisition Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Phoenix Biotech Acquisition Corp. (PBAX) stock price is $5.85. The stock is traded on NASDAQ under the ticker symbol PBAX. The 52-week range is $4.12 – $12.80.